
Organic Process Research and Development p. 1227 - 1238 (2016)
Update date:2022-08-03
Topics:
Williams, Michael J.
Chen, Qinghao
Codan, Lorenzo
Dermenjian, Renee K.
Dreher, Spencer
Gibson, Andrew W.
He, Xianliang
Jin, Yan
Keen, Stephen P.
Lee, Alfred Y.
Lieberman, David R.
Lin, Wei
Liu, Guiquan
McLaughlin, Mark
Reibarkh, Mikhail
Scott, Jeremy P.
Strickfuss, Sophie
Tan, Lushi
Varsolona, Richard J.
Wen, Feng
We describe the route development and multikilogram-scale synthesis of an HCV NS5B site D inhibitor, MK-8876. The key topics covered are (1) process improvement of the two main fragments; (2) optimization of the initially troublesome penultimate step, a key bis(boronic acid) (BBA)-based borylation; (3) process development of the final Suzuki-Miyaura coupling; and (4) control of the drug substance form. These efforts culminated in a 28 kg delivery of the desired active pharmaceutical ingredient.
View MoreNanjing Xi Ze Biological Technology Co., Ltd
Contact:86-025-66023220
Address:Address: Nanjin Qixia District Maigaoqiao R & D base in Pioneer Park Chun Yin Road 18-A928
Taizhou Huading Chemical Co.,Ltd(expird)
Contact:+86-576-88583898
Address:Economic&Technology development zone,Taizhou City,Zhejiang Province,China
Contact:+86 512 6287 2180
Address:398 Ruoshui Road, Suzhou Industrial Park, Suzhou, Jiangsu, P. R. China
Shanggao Ruiya Fine Chemicals Co., Ltd
Contact:+86-795-2592103
Address:Xingguang Nanlu,Shanggao County Industry Park
Shanghai Demand Chemical Co., ltd,China
Contact:86-021-55237578/55239122
Address:Room 3H, No.578, Yingkou Road, Yangpu District, Shanghai, China
Doi:10.1016/0040-4039(94)02477-S
(1995)Doi:10.1038/nchem.2904
(2018)Doi:10.1021/jm050867d
(2006)Doi:10.1248/cpb.43.100
(1995)Doi:10.1021/op500222p
(2014)Doi:10.1016/j.bmcl.2014.07.019
(2014)